United States Continuous Glucose Monitoring Market Size and Growth Analysis

United States Continuous Glucose Monitoring Market Size and Growth Analysis

The United States of America Continuous Glucose Monitoring Market in the United States is witnessing robust expansion, driven by technological advancements and increasing adoption among diabetic patients. With innovation at the forefront, the market is shaping the future of diabetes management through real-time data and enhanced patient compliance.

Market Size and Overview

The United States of America Continuous Glucose Monitoring Market is estimated to be valued at USD 652.2 Mn in 2025 and is expected to reach USD 1177.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

This market growth is propelled by rising diabetes prevalence and greater regulatory approvals for CGM devices, enhancing market revenue and opening new business growth opportunities. Increased focus on remote patient monitoring and integration with mobile health applications also contribute to favorable market trends.

Market Segments

The market analysis reveals three core segment categories: by Product Type, by End User, and by Application.

- Product Type: Consists of Real-Time CGM, Intermittently Scanned CGM (Flash), and Professional CGM systems. Real-Time CGM is the dominant sub-segment, capturing significant market revenue in 2024 owing to continuous monitoring capabilities, while Intermittently Scanned CGM shows the fastest growth supported by rising adoption in home-care settings.
- End User: Hospitals, Ambulatory Care Centers, and Homecare Users are key sub-segments. Homecare Users recorded the fastest growth in 2024 due to the rising trend in self-monitoring and telehealth.
- Application: Pediatric, Adult, and Geriatric Diabetes Management. Adult diabetes management remains dominant, with pediatric segment showing increased uptake driven by rising juvenile diabetes cases and patient-centric interventions in 2024.

Market Drivers

One key driver is the advancement in sensor technology and integration of AI-powered analytics. In 2024, the launch of smaller, more accurate CGM sensors by major market players improved patient adherence and data precision. Regulatory incentives for wearable device reimbursement expanded market opportunities, further propelling market growth. These developments have catalyzed higher CGM penetration in outpatient care and remote health monitoring environments, underscoring the potential for sustained industry size expansion.

Segment Analysis: Product Type

Focusing on product type reveals Real-Time CGM as the dominant revenue-generating segment in 2024, accounting for over 60% of market revenue. Its continuous data feedback system supports proactive glucose management, with multiple successful case studies reported in diabetic patient cohorts across US hospitals. Intermittently Scanned CGM, however, registered the highest CAGR due to cost-effectiveness and simplicity, appealing strongly to homecare users seeking ease of use without continuous connectivity.

Consumer Behaviour Insights

Recent behavior shifts indicate heightened digital consumption habits, with over 70% of CGM users in 2025 actively engaging with integrated smartphone apps for glucose tracking and alerts. Additionally, pricing sensitivity has grown, particularly in outpatient sectors, encouraging market players to offer flexible payment and subscription plans. Customization trends have accelerated, as products now provide personalized data analytics and dietary recommendations, reflecting evolving consumer demand for tailored health management solutions. Sustainability preferences, although emerging, are influencing packaging and device material choices in 2025.

Key Players

Prominent market players dominating the United States Continuous Glucose Monitoring Market share include Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., and F. Hoffmann-La Roche Ltd. In 2024 and 2025, these companies focused on new product launches with enhanced accuracy and extended wear time, capacity expansions across manufacturing facilities, and strategic regional entries into underserved states. Abbott and Dexcom notably advanced cloud-based data sharing platforms, improving market dynamics by enabling remote patient monitoring for clinicians and caregivers.

Key Winning Strategies Adopted by Key Players

1. Abbott’s Rapid Sensor Innovation (2024): Abbott launched a next-gen Freestyle Libre sensor with enhanced interstitial fluid sampling, resulting in a 25% increase in patient retention rates and expanding US outpatient market presence.

2. Dexcom’s Integrated Data Ecosystem (2025): Dexcom’s development of a unified mobile and cloud platform allowed seamless interoperability with insulin pumps and mobile health apps, significantly improving user engagement and adherence.

3. Medtronic’s Subscription-based Model Launch (2024): Medtronic introduced flexible subscription pricing for CGM devices, reducing upfront costs and broadening access, especially among homecare users, boosting business growth in non-hospital settings.

These strategies underscore how innovation aligned with market opportunities can unlock competitive advantage and drive sustainable market growth.

---

FAQs

1. Who are the dominant players in the United States Continuous Glucose Monitoring Market?
Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., and F. Hoffmann-La Roche Ltd. are the leading companies driving market revenue and adopting innovative strategies in 2024 and 2025.

2. What will be the size of the United States Continuous Glucose Monitoring Market in the coming years?
The market size is forecasted to grow from USD 652.2 million in 2025 to USD 1177.0 million by 2032, with a CAGR of 8.8%.

3. Which end user segment has the largest growth opportunity?
The homecare user segment is experiencing the fastest growth driven by digital health solutions and telemedicine integration.

4. How will market trends evolve over the next five years?
Market trends indicate increased adoption of real-time CGM, AI-powered analytics integration, and expansion in outpatient and homecare settings.

5. What are the key challenges in the United States Continuous Glucose Monitoring Market?
Challenges include pricing sensitivity among end users and regulatory hurdles, which companies are addressing through flexible pricing models and technological innovation.

6. What go-to-market strategies are commonly adopted in this market?
Key strategies involve rapid product innovation, cloud-based data sharing platforms, and subscription pricing to enhance accessibility and customer retention.

---

This detailed market report provides comprehensive market insights, enabling expert readers to understand the United States Continuous Glucose Monitoring Market’s scope, dynamics, and growth strategies supported by robust data and real-world examples from 2024 and 2025.

‣ Get More Insights On: United States of America Continuous Glucose Monitoring Market

‣ Get this Report in Japanese Language: アメリカ合衆国の持続血糖測定市場

‣ Get this Report in Korean Language: 미국연속포도당모니터링시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)